Wound Healing Efficacy of Novel Dermal Substitute TissueDerm Graft® in Full-Thickness Skin Defects
Polymers · 31.07.2026 · 18 (15) · 1885
DOI: 10.3390/polym18151885 ↗Kurz gefasst
Fachartikel in der Zeitschrift Polymers, online erschienen am 31.07.2026. Verfasst von Kyu-Sik Shim und 7 weiteren Autor:innen. Beteiligte Einrichtung: PLCOskin Co., Ltd., Seoul 03721, Republic of Korea. Die Arbeit nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of SMEs and Startups, Korea/ Israel Industrial Research and Development Foundation, Ministry of Trade, Industry and Energy.
Themen: Wundversorgung
Abstract (Originalsprache)
Autologous skin grafting is considered the standard treatment for full-thickness skin defects and provides essential dermal reconstruction to support both functional and aesthetic skin outcomes. However, it has limitations, such as increased donor-site morbidity, suboptimal aesthetic outcomes, thickness mismatches, texture irregularities, and scar contractions. Several dermal substitutes have been developed to overcome these limitations. In the present study, we introduce TissueDerm Graft®, a novel collagen-based dermal substitute designed to improve both functional and aesthetic outcomes in skin grafting by providing a regular structure that supports dermal tissue regeneration. We compared the properties and efficacy of TissueDerm Graft® with those of bovine acellular dermal matrix (Matriderm®). A full-thickness skin defect was induced in minipigs and TissueDerm Graft® or Matriderm® were simultaneously transplanted with a split-thickness skin graft (STSG). In the present study, TissueDerm Graft® exhibited tightly packed and uniform collagen fibers, a consistent pore distribution, and elastin. The full-thickness skin defect model demonstrated favorable wound healing without inducing excessive inflammatory responses or excessive scar formation. Compared with the single implantation of STSG and co-implantation of STSG and Matriderm®, the co-implantation of STSG and TissueDerm Graft® improved the visual outcomes. These findings suggest that TissueDerm Graft® could serve as a promising dermal substitute for skin grafting and skin tissue regeneration.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- PLCOskin Co., Ltd., Seoul 03721, Republic of Korea.
- Department of Plastic and Reconstructive Surgery, Institute for Human Tissue Restoration, Severance Hospital, Yonsei University College of Medicine, Seoul 03722, Republic of Korea.
ORCID-Profile: Dohyun Kim, Tai Suk Roh, Wooyeol Baek
Förderung
- Ministry of SMEs and Startups
- Korea/ Israel Industrial Research and Development Foundation
- Ministry of Trade, Industry and Energy
- Technology Development Program of MSS
- Korea/Israel Industrial Research and Development Foundation
- Ministry of Trade Industry & Energy
Zitieren
APA
Shim, K. S., Kim, D., Park, J., Jo, H. S., Koo, N., Lee, W. J., Roh, T. S., & Baek, W. (2026). Wound Healing Efficacy of Novel Dermal Substitute TissueDerm Graft® in Full-Thickness Skin Defects. Polymers, 18(15), 1885. https://doi.org/10.3390/polym18151885
Vancouver
Shim KS, Kim D, Park J, Jo HS, Koo N, Lee WJ, et al. Wound Healing Efficacy of Novel Dermal Substitute TissueDerm Graft® in Full-Thickness Skin Defects. Polymers. 2026;18(15):1885. doi:10.3390/polym18151885
BibTeX
@article{Shim2026,
author = {Shim, Kyu-Sik and Kim, Dohyun and Park, Jeongwoo and Jo, Han-Saem and Koo, Nayeon and Lee, Won Jai and Roh, Tai Suk and Baek, Wooyeol},
title = {Wound Healing Efficacy of Novel Dermal Substitute TissueDerm Graft® in Full-Thickness Skin Defects},
journal = {Polymers},
year = {2026},
volume = {18},
number = {15},
pages = {1885},
doi = {10.3390/polym18151885}
}
EUVIMED